NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $157,843 | +7.2% | 21,244 | 0.0% | 0.03% | -6.7% |
| Q1 2023 | $147,221 | -67.9% | 21,244 | -52.4% | 0.03% | -69.7% |
| Q4 2022 | $458,940 | -43.5% | 44,644 | 0.0% | 0.10% | -47.6% |
| Q3 2022 | $813,000 | -64.6% | 44,644 | 0.0% | 0.19% | -69.1% |
| Q2 2022 | $2,296,000 | -38.3% | 44,644 | -11.7% | 0.61% | -34.7% |
| Q1 2022 | $3,722,000 | -76.3% | 50,544 | -53.9% | 0.94% | -69.2% |
| Q4 2021 | $15,701,000 | -32.8% | 109,744 | -2.7% | 3.05% | -17.0% |
| Q3 2021 | $23,376,000 | -51.9% | 112,760 | -50.7% | 3.67% | -38.8% |
| Q2 2021 | $48,568,000 | +17.1% | 228,760 | 0.0% | 6.00% | -21.6% |
| Q1 2021 | $41,476,000 | +1133.3% | 228,760 | +658.5% | 7.65% | +2163.0% |
| Q4 2020 | $3,363,000 | +43.3% | 30,160 | +39.2% | 0.34% | -48.4% |
| Q3 2020 | $2,347,000 | – | 21,660 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |